UPC_APP_25212/2025

NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY

Procedural & sub-applicationsOther ProceduralThe Hague LDGeneric application—

Overview Decisions Documents Timeline

Parties

Claimants

Genevant Sciences GmbH
Arbutus Biopharma Corporation

Reps: Markus van Gardingen

Respondents

Moderna, Inc.(Moderna Group)
ModernaTX, Inc.(Moderna Group)
Moderna Switzerland GmbH(Moderna Group)
Moderna Netherlands B.V.(Moderna Group)
Moderna Biotech Spain SL(Moderna Group)
Moderna Germany GmbH(Moderna Group)
Moderna France SASU(Moderna Group)
Moderna Italy S.R.L.(Moderna Group)
Moderna Belgium S.R.L.(Moderna Group)
Moderna Denmark ApS(Moderna Group)
Moderna Sweden AB(Moderna Group)
Moderna Norway AS(Moderna Group)
Moderna Portugal Unipessoal LDA(Moderna Group)
Moderna Poland SP. Z.O.O.(Moderna Group)
Moderna Biotech UK Limited(Moderna Group)

Reps: Ruben Laddé; Joachim Renken

Judges

Margot Elsa KokkeJudge-rapporteur

Patents

EP2279254
EP4241767

CPC codes: C07J9/00, A61P31/14, A61K9/1271, C12N15/111, C12N2310/14, C12N15/113, A61K9/1272, A61P35/00, A61K31/713, C12N2320/32, A61P31/12, C12N15/1137…

Sector: Biotechnology

Outcome

Procedural only

Filed: —

First decided: Jun 4, 2025

Language: —